IBSS Biomed S.A.
Quick facts
Phase 3 pipeline
- Clodivac · Other
- Td-Impfstoff Merieux · Infectious Diseases
Td-Impfstoff Merieux is a vaccine that stimulates the body's immune response to diphtheria and tetanus.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about IBSS Biomed S.A.
What is IBSS Biomed S.A.'s pipeline?
IBSS Biomed S.A. has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Clodivac, Td-Impfstoff Merieux.
Related
- Sector hub: All tracked pharma companies